Romvimza (vimseltinib), FDA Approved for Treatment of Tenosynovial Giant Cell Tumor (TGCT), Available at Biologics by McKesson
Biologics by McKesson was selected as a distribution specialty pharmacy provider for ROMVIMZA, approved for adults with symptomatic tenosynovial giant cell tumor when surgery could cause severe morbidity.